Paper31258685
Reduced miR-202 levels enhanced oral cancer development via targeting Sp1.
Zhao J and 2 others. Exp Ther Med, 2019. Cited by 6 papers, by iCite. Retracted.
Cite this record
ConductScience Library. Reduced miR-202 levels enhanced oral cancer development via targeting Sp1. Papers, record 31258685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31258685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Retracted by | 38682115 | [Retracted] Reduced miR‑202 levels enhanced oral cancer development via targeting Sp1. | https://conductscience.org/library/papers/38682115 |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11846609 | Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. | Methods | 2001 | https://conductscience.org/library/papers/11846609 | PubMed |
| 2 | 23731011 | MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer. | Oral Dis | 2014 | https://conductscience.org/library/papers/23731011 | PubMed |
| 3 | 24669014 | GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma. | Ann Oncol | 2014 | https://conductscience.org/library/papers/24669014 | PubMed |
| 4 | 25500095 | miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer. | Oral Oncol | 2015 | https://conductscience.org/library/papers/25500095 | PubMed |
| 5 | 26879838 | Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction. | J Formos Med Assoc | 2017 | https://conductscience.org/library/papers/26879838 | PubMed |
| 6 | 27235675 | Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B. | J Pathol | 2016 | https://conductscience.org/library/papers/27235675 | PubMed |
| 7 | 27581787 | Micronome revealed miR-19a/b as key regulator of SOCS3 during cancer related inflammation of oral squamous cell carcinoma. | Gene | 2016 | https://conductscience.org/library/papers/27581787 | PubMed |
| 8 | 28077301 | MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma. | Exp Cell Res | 2017 | https://conductscience.org/library/papers/28077301 | PubMed |
| 9 | 28095864 | MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis. | Mol Cancer | 2017 | https://conductscience.org/library/papers/28095864 | PubMed |
| 10 | 28117748 | Decreased Sp1 Expression Mediates Downregulation of SHIP2 in Gastric Cancer Cells. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28117748 | PubMed |
| 11 | 28146434 | Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes. | Oncotarget | 2017 | https://conductscience.org/library/papers/28146434 | PubMed |
| 12 | 28225083 | Antitumorigenic effect of atmospheric-pressure dielectric barrier discharge on human colorectal cancer cells via regulation of Sp1 transcription factor. | Sci Rep | 2017 | https://conductscience.org/library/papers/28225083 | PubMed |
| 13 | 28290615 | MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5. | Genet Mol Res | 2017 | https://conductscience.org/library/papers/28290615 | PubMed |
| 14 | 28484232 | Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer. | Sci Rep | 2017 | https://conductscience.org/library/papers/28484232 | PubMed |
| 15 | 28529241 | Downregulation of Transcription Factor Sp1 Suppresses Malignant Properties of A549 Human Lung Cancer Cell Line with Decreased β4-Galactosylation of Highly Branched N-Glycans. | Biol Pharm Bull | 2017 | https://conductscience.org/library/papers/28529241 | PubMed |
| 16 | 28569779 | Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28569779 | PubMed |
| 17 | 28846829 | RhoGDIβ promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation. | Mol Oncol | 2017 | https://conductscience.org/library/papers/28846829 | PubMed |
| 18 | 28887525 | MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition. | Sci Rep | 2017 | https://conductscience.org/library/papers/28887525 | PubMed |
| 19 | 29048658 | Functional diversity of miR-146a-5p and TRAF6 in normal and oral cancer cells. | Int J Oncol | 2017 | https://conductscience.org/library/papers/29048658 | PubMed |
| 20 | 29048687 | SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab‑resistant ovarian cancer model. | Oncol Rep | 2017 | https://conductscience.org/library/papers/29048687 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35682549 | The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682549 | PubMed |
| 34042273 | Reduced serum miR-202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein. | Kaohsiung J Med Sci | 2021 | https://conductscience.org/library/papers/34042273 | PubMed |
| 33344262 | Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/33344262 | PubMed |
| 33125090 | MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway. | Int J Mol Med | 2020 | https://conductscience.org/library/papers/33125090 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| MIR202 | 574448 | PubTator's text mining | https://conductscience.org/library/genes/574448 | NCBI Gene |
| PTK2B | 2185 | PubTator's text mining | https://conductscience.org/library/genes/2185 | NCBI Gene |
| SP1 | 6667 | PubTator's text mining | https://conductscience.org/library/genes/6667 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31258685
GET https://conductscience.org/api/papers/v1/31258685/references?page=2